SCHEMBL7046362

SCHEMBL7046362

CCOC(=O)c1c(C)c2c(n1Cc1ccc(Cl)c(Cl)c1)CCCC2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.51
HDAC6 Q9UBN7 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
UBE2N P61088 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
TP53 P04637 2/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049001 0.90 SMN1; SMN2 (0.45) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7048313 0.87 HDAC1 (0.52) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7954271 0.84 LMNA (0.50) SMN1; SMN2MAPTLMNAGAAHTT
SCHEMBL7048131 0.84 HDAC1 (0.52) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7050364 0.84 HDAC1 (0.42) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7050361 0.82 TSHR (0.43) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7046229 0.82 HDAC1 (0.40) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7050359 0.82 HDAC1 (0.40) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7050842 0.81 HDAC1 (0.48) HDAC1HDAC6SMN1; SMN2MAPTLMNA
SCHEMBL7158730 0.80 RAB9A (0.46) HDAC1HDAC6SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054667-B1 BICYCLIC PYRROLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIINFLAMMATORY AND IMMUNOMODULATING AGENTS ASTRAZENECA UK LTD (GB) 2003-04-16 EP disclosed
US-6291507-B1 INHIBITOR OF MONOCYTE CHEMOATTRACTANT PROTEIN-1; INDOLE DERIVATIVES ASTRAZENECA UK LIMITED (GB) 2001-09-18 US disclosed
EP-1054667-A1 BICYCLIC PYRROLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIINFLAMMATORY AND IMMUNOMODULATING AGENTS AstraZeneca UK Limited (GB) 2000-11-29 EP disclosed
WO-1999040913-A1 CHEMICAL COMPOUNDS ASTRAZENECA UK LIMITED (GB) 1999-08-19 WO disclosed